We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Lab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but different treatments, requiring a fast, differential test to...
All eyes were on a California-based biotech company on Monday after a few announcements came across the newswires earlier in the session.
By Dia Gill Lucira Health Inc. shares soared 340.7% to 62 cents Monday morning after the medical technology company announced it was seeking a strategic partner to help resume manufacturing of its...
By Dia Gill Lucira Health Inc. is seeking a strategic or financial partner to aid resumption of manufacturing for its Covid-19 & Flu test, which received emergency authorization from the U.S...
Lab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but different treatments, requiring a fast, differential test to...
By Sabela Ojea Lucira Health Inc. on Friday received the U.S. Food and Drug Administration's emergency use authorization for its Covid-19 and Flu diagnostic test. Shares of the company, which...
By Denny Jacob Lucira Health Inc. shares doubled in after-hours trading Friday following the Food and Drug Administration's emergency use authorization for its diagnostic test. The FDA said...
EMERYVILLE, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company, announced today that it has...
SESAME PARTNERS WITH LUCIRA HEALTH AS OFFICIAL TELEHEALTH PROVIDER OF LAB-QUALITY TEST-TO-TREAT PROGRAM PR Newswire NEW YORK, Jan. 5, 2023 New partnership enables a free Sesame telehealth...
By Chris Wack Lucira Health Inc. shares were down 28% at 43 cents, one day after the company said it submitted an Emergency Use Authorization application to the Food and Drug Administration for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions